Macrophages in the BM of MPN patients have recently gained increased clinical attention, as they have been shown to be attractive novel cellular therapeutic targets, particularly as they play a significant role in inducing proliferating myofibroblasts via vitamin D receptor signaling [8]. This evidence concerns the gene VDR and myeloproliferative disorder.